Myomo (MYO) Debt to Equity (2017 - 2025)
Myomo (MYO) reported Debt to Equity of $0.24 for Q4 2025, up 500.95% quarter-over-quarter from $0.04 in Q3 2025.
Myomo (MYO) Debt to Equity (2017 - 2025) Analysis & Trends
Myomo has reported Debt to Equity for 5 years, with the latest figure at $0.24 in Q4 2025.
- For the quarter ending Q4 2025, Debt to Equity changed N/A year-over-year to $0.24; the trailing twelve-month figure through Dec 2025 stood at $0.24 (changed N/A YoY), and the FY2025 full-year result was $0.24, changed N/A from the prior year.
- Debt to Equity for Q4 2025 stood at $0.24, up from $0.04 in the prior quarter.
- The five-year high for Debt to Equity was $0.24 in Q4 2025, with the low at $0.04 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 0.06 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 0.95 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.71 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 0.27 |
| 10 | Myomo | 45.01 Mn | 26.62 Mn | - | 0.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.24 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.14 |
| Jun 30, 2020 | 0.01 |
| Mar 31, 2020 | 0.12 |
| Dec 31, 2019 | 0.20 |
| Sep 30, 2019 | 0.01 |
| Jun 30, 2019 | 0.01 |
| Mar 31, 2019 | 0.02 |
| Dec 31, 2018 | 0.00 |
| Sep 30, 2018 | 0.00 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 0.00 |
| Dec 31, 2017 | 0.00 |
| Sep 30, 2017 | 0.38 |
| Jun 30, 2017 | 0.22 |